Jul 9 |
FTC Investigation Uncovers Anti-Competitive Practices By Handful Of Pharmacy Benefit Managers, Including CVS Health, UnitedHealth
|
Jul 9 |
Powell's Senate testimony, FTC ruling on drug prices: Catalysts
|
Jul 9 |
CVS Health: A Better Investment Than Walgreens Boots Alliance
|
Jul 9 |
US FTC Report Says Pharmacy Benefit Managers Contribute to Higher Drug Costs
|
Jul 9 |
Pharma middlemen benefit at the expense of patients: FTC
|
Jul 9 |
Middlemen have outsized influence on US drug prices due to market consolidation, FTC says
|
Jul 8 |
CVS Health (CVS) Falls 24% in 3 Months: Should You Buy the Dip?
|
Jul 8 |
CVS Health to hold second quarter 2024 earnings conference call
|
Jul 8 |
Here’s Why CVS Health Corporation (CVS) Slipped in Q2
|
Jul 7 |
CVS Health: Good Buy Vs. Goodbye
|